BCG vaccine (Vakzine Project Management/Serum Institute of India)

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameBCG vaccine (Vakzine Project Management/Serum Institute of India)
Drug Alias NamerBCGdeltaUreCHly卡介苗 - Vakzine Project Management/Serum Institute of IndiarBCG-delta-ureC-HlyVPM-1002BCVPM-1002
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Urinary Bladder NeoplasmsOvarian Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUganda +[9] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMax Planck Institute For Infection Biology
China Registration ClassN/A

Develop Information

Active CompaniesImmunitybio IncSerum Institute Of India Pvt LtdVakzine Projekt Management Gmbh +[6] 
Inactive CompaniesSerum Life Science Europe GmbHEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentNational Cancer Institute +[5] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Urinary Bladder NeoplasmsTuberculosis
Inactive IndicationsOvarian NeoplasmsHIV InfectionsRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A